Genomics, U of Oxford Collaborate on Sequence Analysis | GenomeWeb

NEW YORK (GenomeWeb) – British informatics firm Genomics plc today announced a collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust to analyze genomic sequences in rare diseases and cancer.

Under the terms of the agreement, the partners will work on a pilot study to establish genome sequencing as a clinical tool in rare diseases, cancers, and other disorders. Genomics will use its software to analyze up to 500 genome sequences, linking genotypes and phenotypes.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.